Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSI-GSD 200 (RVF Vaccine) in Adults at Risk of Rift Valley Fever
NCT03609398Phase 2Recruiting
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Oct 2018
- Primary completion
- Dec 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of rift valley fever vaccine (inactivated) in Rift Valley fever (RVF), sponsored by U.S. Army Medical Research and Development Command. Started Oct 2018; status: recruiting.
02
Drugs
rift valley fever vaccine (inactivated)
03
Conditions
Rift Valley fever (RVF)
Beyond the preview
Go deeper on NCT03609398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03609398.